Natural killer (NK) cells represent a small population of cytotoxic cells in normal peripheral blood that appear morphologically to be a homogeneous population of large granular lymphocytes. Despite their uniform morphology, NK cells have been attributed to have a variety of diverse immunologic functions including resistance to malignant or virally transformed cells, rejection of allogeneic grafts and hematopoietic regulation, and phenotypic studies have indicated that they express a variety of both T cell and myeloid surface antigens. In order to analyze the structural basis by which NK cells interact with target cells in the context of this extensive heterogeneity, we have developed methods for initiating and maintainting growth of NK cells in vitro. This has resulted in the establishment of a large series of clonal cell lines which maintain NK activity after prolonged periods of culture. Both phenotypic and functional analysis of these NK clones suggests that they accurately reflect the diversity of NK cells in peripheral blood. Based on the phenotype of these NK clones, three major groups have been identified: 1) cells that express no lineage associated antigens; 2) cells with a mautre T cell phenotype (T3+T11+); and 3) those with various combinations of myeloid and T cell antigens, but without expression of T3 antigen (T3-T11+). Recent experiments with T3+T11+ NK clones have demonstrated that even though they do not have MHC restricted CTL-like specificity, these cells utilize a functional T cell receptor to specifically interact with a target antigen that is expressed on various hematopoietic cells after cell activation. Although the analysis of T3+T11+ NK clones has identified a unique functional population of cytolytic cells, other types of NK clones do not express clonotypic T cell receptor-like structures and must therefore utilize other mechanisms for interaction with target cell antigens. In future studies we propose to continue the analysis of NK cell function utilizing monoclonal antibodies to identify functional structures on NK clones. In addition to further studies with T3+, T11+ clones, major efforts will be directed towards the characterization of functional antigens on T3-T11+ NK clones that represent the majority of NK cells. Utilizing monoclonal antibodies directed at NK associated antigens as well as antibodies to functional NK structures, we will also be able to extend our analysis to unstimulated NK cells in peripheral blood. Finally, NK clones will also be utilized to analyze potential mechanisms for the regulation of NK cell activity.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA041619-02
Application #
3182319
Study Section
Experimental Immunology Study Section (EI)
Project Start
1986-07-01
Project End
1989-12-31
Budget Start
1988-01-01
Budget End
1988-12-31
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Wang, K S; Zorn, E; Ritz, J (2001) Specific down-regulation of interleukin-12 signaling through induction of phospho-STAT4 protein degradation. Blood 97:3860-6
Mahajan, S; Gollob, J A; Ritz, J et al. (2001) CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells. Exp Hematol 29:209-20
Wang, K S; Frank, D A; Ritz, J (2000) Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. Blood 95:3183-90
Wang, K S; Ritz, J; Frank, D A (1999) IL-2 induces STAT4 activation in primary NK cells and NK cell lines, but not in T cells. J Immunol 162:299-304
Robertson, M J; Cameron, C; Atkins, M B et al. (1999) Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin Cancer Res 5:9-16
Frank, D A; Mahajan, S; Ritz, J (1999) Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med 5:444-7
Gollob, J A; Schnipper, C P; Murphy, E A et al. (1999) The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. J Immunol 162:4472-81
Gollob, J A; Murphy, E A; Mahajan, S et al. (1998) Altered interleukin-12 responsiveness in Th1 and Th2 cells is associated with the differential activation of STAT5 and STAT1. Blood 91:1341-54
David, D; Bani, L; Moreau, J L et al. (1998) Further analysis of interleukin-2 receptor subunit expression on the different human peripheral blood mononuclear cell subsets. Blood 91:165-72
David, D; Bani, L; Moreau, J L et al. (1998) Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci U S A 95:11348-53

Showing the most recent 10 out of 53 publications